The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

ConditionHPV Infection

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age25-65

SponsorLo.Li.Pharma s.r.l

About this trial

The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

HR-HPV DNA test positivity

Disqualifiers

No HSIL

Trial design

Design model

Parallel

Treatments tested in this trial

EGCG + folic acid + B12
Dietary supplement
EGCG + folic acid + B12

Treatment groups

100 Participants

are divided into 2 treatment groups

Group A: controlNo intervention 0 interventions

Group B: treatmentExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

HPV DNA test negativity

Percentage

Time frame

8 months of treatment

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Lo.Li.Pharma s.r.l

Lead sponsor

Source ClinicalTrials.gov

Apply now